PANCREATIC ENZYME ABNORMALITY

This adverse event was reported 102 times

PANCREATIC ENZYME ABNORMALITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CROVALIMAB 1 0.0083
1 NITROFURANTOIN (MACROCRYSTALS) 1 0.0016
2 OXAPROZIN 1 0.0011
3 BETAINE 1 0.0010
4 NISOLDIPINE 1 0.0008
5 TRIMETHOBENZAMIDE HYDROCHLORIDE 1 0.0007
6 PIPERACILLIN AND TAZOBACTAM 8 0.0006
7 PANCRELIPASE 23 0.0006
8 DHEA (DEHYDROEPIANDROSTERONE) 1 0.0005
9 MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN 1 0.0005
See all drugs enriched for association with PANCREATIC ENZYME ABNORMALITY

PANCREATIC ENZYME ABNORMALITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Complement C5 Inhibitor [EPC] 1 0.0083
1 Methylating Agent [EPC] 1 0.0010
2 Benzothiazole [EPC] 1 0.0004
3 beta Lactamase Inhibitor [EPC] 2 0.0004
4 Nitrogen Binding Agent [EPC] 1 0.0004
5 Provitamin D2 Compound [EPC] 5 0.0002
6 Aluminum Complex [EPC] 3 0.0001
7 Sigma-1 Agonist [EPC] 1 0.0001
8 Fluoroquinolone Antibacterial [EPC] 11 0.0001
9 Microtubule Inhibitor [EPC] 14 0.0001
See all drug classes enriched for association with PANCREATIC ENZYME ABNORMALITY